Authors:
Hawley-Foss, N
Mbisa, G
Lum, JJ
Pilon, AA
Angel, JB
Garber, G
Badley, AD
Citation: N. Hawley-foss et al., Effect of cessation of highly active antiretroviral therapy during a discordant response: Implications for scheduled therapeutic interruptions, CLIN INF D, 33(3), 2001, pp. 344-348
Authors:
Bernard, GR
LaRosa, SP
Laterre, PF
Ely, EW
Dhainaut, JF
Fisher, CJ
Lopez-Rodriguez, A
Helterbrand, J
Steingrub, J
Garber, G
Vincent, JL
Citation: Gr. Bernard et al., The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000), CRIT CARE M, 29(2), 2001, pp. 469-469
Authors:
Boogaerts, M
Winston, DJ
Bow, EJ
Garber, G
Reboli, AC
Schwarer, AP
Novitzky, N
Boehme, A
Chwetzoff, E
De Beule, K
Citation: M. Boogaerts et al., Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy- A randomized, controlled trial, ANN INT MED, 135(6), 2001, pp. 412-422
Authors:
Yamamura, DLR
Rotstein, C
Nicolle, LE
Ioannou, S
Johnston, L
Schlech, W
Thompson, GW
Beliveau, C
Gourdeau, M
Tremblay, CA
Bourgault, AM
Noel, G
St Germain, G
Garber, G
Evans, G
Conly, J
Krajden, S
Walmsley, S
Wang, E
Rotstein, C
Gregson, D
Nicolle, L
Williams, K
Louie, T
Phillips, P
Citation: Dlr. Yamamura et al., Candidemia at selected Canadian sites: Results from the fungal disease registry, 1992-1994, CAN MED A J, 160(4), 1999, pp. 493-499